{"id":56032,"date":"2023-04-20T10:03:08","date_gmt":"2023-04-20T08:03:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/"},"modified":"2023-04-20T10:03:08","modified_gmt":"2023-04-20T08:03:08","slug":"sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/","title":{"rendered":"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy"},"content":{"rendered":"
\n

\nMcCarthy\u2019s experience and network will help identify early-stage biotech companies <\/i>developing sustainable solutions in agriculture, food, chemicals, and materials<\/i><\/p>\n

\nNew partner bolsters Sofinnova\u2019s continuing expansion and pioneering role in environmental impact through biotech investments<\/i><\/p>\n

PARIS–(BUSINESS WIRE)–Sofinnova Partners<\/a> (\u201cSofinnova\u201d), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the appointment of Mary McCarthy as Partner at Sofinnova Partners, joining the growing Sofinnova Industrial Biotech Strategy<\/a> team. She will use her extensive experience and network to help identify the most promising early-stage companies developing biotech-enabled sustainable solutions in agriculture, food, chemicals, and materials. The Sofinnova Industrial Biotech Strategy has made 24 investments to date and is actively investing out of its third fund of \u20ac175M.<\/p>\n

<\/a>
<\/a><\/p>\n

\nBefore joining Sofinnova Partners, Mary was a Partner at Brightlands Venture Partners (BVP) where she was the Fund Manager of the BVP Renewable Chemistry Fund and served on various boards. With over 24 years in chemistry and materials, Mary has occupied various roles in the sector: She was CEO of a start-up developing materials for the circular economy and worked at SABIC for 15 years, where she held various functions in R&D, HR, Change Management, and Corporate Venturing.<\/p>\n

\nMichael Krel, Partner at Sofinnova Partners<\/b>, said: “Mary is a perfect addition to our team with broad experience in the venture, start-up and corporate world. This appointment is another step forward in the growth of our industrial biotech strategy; it bolsters our commitment to identifying and supporting early-stage companies that have the potential to develop innovations with strong environmental impact.”<\/p>\n

\nJo\u0161ko Bobanovi\u0107, Partner at Sofinnova Partners<\/b>, said: “Mary joins our team at an exciting time of growth and evolution of the industrial biotech ecosystem. With her track record of successful investments, Mary will strengthen our capacity to meet the increasing demand for innovative and sustainable solutions for the environment.”<\/p>\n

\nMary McCarthy, Partner at Sofinnova Partners<\/b>, said: “I’m very pleased to join Sofinnova Partners. The Industrial Biotech team is a recognized pioneer in the sector with a wealth of accumulated knowledge. I am looking forward to contributing to the team\u2019s mission of finding deeptech solutions with strong environmental impact that can truly change the world for the better.”<\/p>\n

\nAntoine Papiernik, Chairman and Managing Partner at Sofinnova Partners<\/b>, said: “Mary\u2019s appointment strengthens Sofinnova\u2019s leadership position in industrial biotech and reinforces the work this team has been doing for over a decade in forging a strong platform through investments in sustainability. Industrial biotech is a crucial pillar for the future of our firm, and Mary\u2019s extensive network, ability to recognize disruptive technology, and genuine commitment to make the global economy more sustainable will undoubtedly contribute to accelerating this trajectory.”<\/p>\n

\nMary holds a PhD in chemistry from University College Dublin, Ireland and held postdoctoral fellowships at the University of Amsterdam, the Netherlands and the Max Planck Institute f\u00fcr Kohlenforschung, Germany.<\/p>\n

\nAbout Sofinnova Partners
\n
<\/b>Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.<\/p>\n

\nFounded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over \u20ac2.5 billion under management. For more information, please visit: sofinnovapartners.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nBommy Lee<\/b>
Head of Communications
\n
Sofinnova Partners
\n
blee@sofinnovapartners.com<\/a>
+33 (0) 6 47 71 38 11<\/p>\n

\nNorth America<\/b>
RooneyPartners LLC
\n
Kate Barrette
\n
kbarrette@rooneypartners.com<\/a><\/span>
+1 212 223 0561<\/p>\n

\nUnited Kingdom<\/b>
Optimum Strategic Communications
\n
Hollie Vile
\n
sofinnova@optimumcomms.com<\/a>
<\/b>+44 (0) 20 3922 0900<\/p>\n

\nFrance<\/b>
StrategiesImage
\n
Anne Rein
\n
anne.rein@strategiesimage.com<\/a>
+33 (0) 6 03 35 92 05<\/p>\n

\nItaly<\/b>
Havas PR Milan
\n
Pierluigi Cavarai
\n
pierluigi.cavaraiext@havaspr.com<\/a><\/span>
+39 (0) 392 77 999<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

McCarthy\u2019s experience and network will help identify early-stage biotech companies developing sustainable solutions in agriculture, food, chemicals, and materials New partner bolsters Sofinnova\u2019s continuing expansion and pioneering role in environmental impact through biotech investments PARIS–(BUSINESS WIRE)–Sofinnova Partners (\u201cSofinnova\u201d), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the appointment … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56032","6":"format-standard","7":"category-industry"},"yoast_head":"\nSofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"McCarthy\u2019s experience and network will help identify early-stage biotech companies developing sustainable solutions in agriculture, food, chemicals, and materials New partner bolsters Sofinnova\u2019s continuing expansion and pioneering role in environmental impact through biotech investments PARIS–(BUSINESS WIRE)–Sofinnova Partners (\u201cSofinnova\u201d), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the appointment ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T08:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230420005098\/en\/1768530\/21\/Delporte-MaryMcCarthy02-2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy\",\"datePublished\":\"2023-04-20T08:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/\"},\"wordCount\":680,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005098\\\/en\\\/1768530\\\/21\\\/Delporte-MaryMcCarthy02-2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/\",\"name\":\"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005098\\\/en\\\/1768530\\\/21\\\/Delporte-MaryMcCarthy02-2.jpg\",\"datePublished\":\"2023-04-20T08:03:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005098\\\/en\\\/1768530\\\/21\\\/Delporte-MaryMcCarthy02-2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005098\\\/en\\\/1768530\\\/21\\\/Delporte-MaryMcCarthy02-2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/","og_locale":"en_US","og_type":"article","og_title":"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy - Pharma Trend","og_description":"McCarthy\u2019s experience and network will help identify early-stage biotech companies developing sustainable solutions in agriculture, food, chemicals, and materials New partner bolsters Sofinnova\u2019s continuing expansion and pioneering role in environmental impact through biotech investments PARIS–(BUSINESS WIRE)–Sofinnova Partners (\u201cSofinnova\u201d), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the appointment ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-20T08:03:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230420005098\/en\/1768530\/21\/Delporte-MaryMcCarthy02-2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy","datePublished":"2023-04-20T08:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/"},"wordCount":680,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420005098\/en\/1768530\/21\/Delporte-MaryMcCarthy02-2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/","url":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/","name":"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420005098\/en\/1768530\/21\/Delporte-MaryMcCarthy02-2.jpg","datePublished":"2023-04-20T08:03:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230420005098\/en\/1768530\/21\/Delporte-MaryMcCarthy02-2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230420005098\/en\/1768530\/21\/Delporte-MaryMcCarthy02-2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firms-industrial-biotech-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm\u2019s Industrial Biotech Strategy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56032"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56032\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}